tradingkey.logo
tradingkey.logo
Search

enVVeno Medical Corp

NVNO
Add to Watchlist
10.570USD
-0.056-0.53%
Close 07-31 16:00ETQuotes delayed by 15 min
7.11MMarket Cap
LossP/E TTM

NVNO Income Statement

You can find the annual or quarterly income statement of enVVeno Medical Corp here for insights into the performance and operational efficiency of enVVeno Medical Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2015Q4
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
0.57%31.24K
-82.61%30.46K
49.43%41.66K
114.85%83.36K
-82.77%31.07K
-42.56%175.12K
-90.56%27.88K
--38.80K
--180.31K
--304.86K
--295.47K
--0.00
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
-98.18%2.40K
--13.60K
--54.40K
-100.00%0.00
-53.14%132.00K
-100.00%0.00
--0.00
--152.40K
--281.72K
--262.80K
--0.00
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
----
----
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
-53.78%97.98K
-66.51%132.94K
--0.00
--188.73K
--212.00K
--396.93K
--0.00
Operating expenses
-46.15%3.80M
-18.01%4.06M
-40.10%4.01M
-20.86%4.88M
29.24%7.05M
-9.98%4.95M
6.71%6.70M
15.35%6.17M
-19.96%5.45M
-19.04%5.50M
-2.82%6.28M
-13.04%5.35M
-2.46%6.81M
27.40%6.80M
-28.16%6.46M
127.27%6.15M
192.86%6.99M
89.98%5.33M
116.24%8.99M
40.80%2.71M
54.31%2.39M
86.16%2.81M
143.16%4.16M
4.81%1.92M
-21.13%1.55M
-6.51%1.51M
13.27%1.71M
19.93%1.83M
-38.66%1.96M
8.48%1.61M
-28.24%1.51M
-16.89%1.53M
151.48%3.20M
13.47%1.49M
46.05%2.10M
35.72%1.84M
--1.27M
--1.31M
146.86%1.44M
--1.36M
--583.51K
R&D expenses
-28.19%2.08M
-17.44%2.11M
-44.55%1.95M
-9.58%2.58M
2.34%2.89M
-16.22%2.56M
17.85%3.51M
2.18%2.86M
-32.96%2.83M
-15.10%3.05M
6.58%2.98M
12.28%2.80M
37.13%4.21M
131.64%3.59M
57.00%2.80M
103.50%2.49M
182.00%3.07M
-4.89%1.55M
-21.77%1.78M
61.51%1.22M
54.31%1.09M
219.57%1.63M
189.06%2.28M
12.00%758.20K
64.87%706.17K
63.13%510.62K
168.66%787.83K
59.44%676.97K
52.74%428.31K
30.15%313.01K
-16.00%293.24K
885.85%424.60K
51.64%280.42K
230.98%240.49K
--349.09K
--43.07K
--184.92K
--72.66K
----
--0.00
----
Depreciation, depletion, and amortization
----
-74.59%31.00K
-74.59%31.00K
-75.97%31.00K
-75.00%34.00K
-13.48%122.00K
-8.96%122.00K
-6.52%129.00K
-1.45%136.00K
3.68%141.00K
3.08%134.00K
3.76%138.00K
3.76%138.00K
5.43%136.00K
6.92%130.00K
10.71%133.00K
23.72%133.00K
24.42%129.00K
26.69%121.59K
21.92%120.14K
3.97%107.50K
20.47%103.68K
-22.71%95.98K
-17.64%98.54K
-1.01%103.39K
-8.84%86.06K
269.25%124.18K
258.47%119.65K
214.54%104.45K
184.32%94.41K
1.13%33.63K
1.00%33.38K
-8.20%33.21K
-9.62%33.21K
-18.40%33.25K
-18.82%33.05K
--36.17K
--36.74K
39.81%40.75K
--40.71K
--29.15K
Operating profit
46.15%-3.80M
18.01%-4.06M
40.10%-4.01M
20.86%-4.88M
-29.24%-7.05M
9.98%-4.95M
-6.71%-6.70M
-15.35%-6.17M
19.96%-5.45M
19.04%-5.50M
2.82%-6.28M
13.04%-5.35M
2.46%-6.81M
-27.40%-6.80M
28.16%-6.46M
-127.27%-6.15M
-192.86%-6.99M
-89.98%-5.33M
-116.24%-8.99M
-40.80%-2.71M
-54.31%-2.39M
-86.16%-2.81M
-143.16%-4.16M
-4.81%-1.92M
21.13%-1.55M
4.67%-1.51M
-15.61%-1.71M
-23.28%-1.83M
37.02%-1.96M
-8.64%-1.58M
23.30%-1.48M
17.91%-1.49M
-152.63%-3.11M
-28.82%-1.46M
-69.84%-1.93M
-70.91%-1.81M
---1.23M
---1.13M
-94.61%-1.14M
---1.06M
---583.51K
Net non-operating interest income (expenses)
Gains from sale of securities
16.88%187.00K
-15.95%195.00K
-43.32%174.00K
-61.06%169.00K
-62.35%160.00K
-48.67%232.00K
-46.79%307.00K
42.76%434.00K
41.20%425.00K
25.56%452.00K
144.49%577.00K
1547.62%304.00K
366.37%301.00K
--360.00K
--236.00K
---21.00K
---113.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Return on equity
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
--487.90K
---487.90K
----
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
----
----
--0.00
689.49%312.70K
----
-100.00%0.00
100.00%0.00
---53.05K
---81.28K
--346.13K
-84.22%-588.82K
--0.00
-100.00%0.00
-100.00%0.00
-239.59%-319.63K
-100.00%0.00
729.93%183.81K
6365.17%1.49M
157.64%228.99K
15.91%4.05K
--22.15K
---23.77K
-224541.24%-397.26K
--3.49K
--177.00
- Gains from disposal of fixed assets
----
---4.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
100.00%0.00
--0.00
--867.00
--32.41K
---215.91K
----
----
----
--0.00
-100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
103.37%12.50K
-8385.57%-2.01M
---4.57M
-169.59%-1.32M
-176.89%-371.15K
---23.63K
--0.00
---487.90K
--482.70K
--0.00
Income before tax
----
14.52%-3.85M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.50M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
8.59%-5.65M
17.98%-5.00M
8.33%-6.47M
-19.92%-6.39M
31.24%-6.18M
-155.18%-6.10M
-196.99%-7.06M
-92.22%-5.33M
-105.48%-8.99M
-20.99%-2.39M
-46.16%-2.38M
-139.09%-2.77M
-90.94%-4.37M
-8.81%-1.97M
16.40%-1.63M
26.30%-1.16M
-28.58%-2.29M
-23.62%-1.81M
61.43%-1.95M
66.85%-1.57M
42.97%-1.78M
34.89%-1.47M
-303.98%-5.05M
-307.98%-4.75M
-102.83%-3.12M
-109.49%-2.25M
---1.25M
---1.16M
-146.83%-1.54M
---1.08M
---624.01K
Income tax
----
----
---4.24M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
--0.00
Income after tax
----
14.52%-3.85M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.50M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
8.59%-5.65M
17.98%-5.00M
8.33%-6.47M
-19.92%-6.39M
31.24%-6.18M
-155.18%-6.10M
-196.99%-7.06M
-92.22%-5.33M
-105.48%-8.99M
-20.99%-2.39M
-46.16%-2.38M
-139.09%-2.77M
-90.94%-4.37M
-8.81%-1.97M
16.40%-1.63M
26.30%-1.16M
-28.58%-2.29M
-23.62%-1.81M
61.43%-1.95M
66.85%-1.57M
42.97%-1.78M
34.89%-1.47M
-303.98%-5.05M
-307.98%-4.75M
-102.83%-3.12M
-109.49%-2.25M
---1.25M
---1.16M
-146.83%-1.54M
---1.08M
---624.01K
Net income from continuous operations
46.22%-3.60M
14.52%-3.85M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.50M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
8.59%-5.65M
17.98%-5.00M
8.33%-6.47M
-19.92%-6.39M
31.24%-6.18M
-155.18%-6.10M
-196.99%-7.06M
-92.22%-5.33M
-105.48%-8.99M
-20.99%-2.39M
-46.16%-2.38M
-139.09%-2.77M
-90.94%-4.37M
-8.81%-1.97M
16.40%-1.63M
26.30%-1.16M
-28.58%-2.29M
-23.62%-1.81M
61.43%-1.95M
66.85%-1.57M
42.97%-1.78M
34.89%-1.47M
-303.98%-5.05M
-307.98%-4.75M
-102.83%-3.12M
-109.49%-2.25M
---1.25M
---1.16M
-146.83%-1.54M
---1.08M
---624.01K
Net income from discontinued operations
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
----
-100.00%0.00
--0.00
--66.07K
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
Net income attributable to controlling interests
46.22%-3.60M
14.52%-3.85M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.50M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
8.59%-5.65M
17.98%-5.00M
8.33%-6.47M
-19.92%-6.39M
31.24%-6.18M
-155.18%-6.10M
-196.99%-7.06M
-92.22%-5.33M
-81.30%-8.99M
-19.55%-2.39M
-46.16%-2.38M
-139.09%-2.77M
-116.41%-4.96M
-10.12%-2.00M
16.40%-1.63M
26.30%-1.16M
-28.58%-2.29M
-23.62%-1.81M
76.34%-1.95M
67.73%-1.57M
45.22%-1.78M
38.09%-1.47M
-503.68%-8.23M
-285.57%-4.88M
-98.41%-3.25M
-102.58%-2.37M
---1.36M
---1.26M
-191.51%-1.64M
---1.17M
---562.30K
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
----
--583.36K
--23.86K
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
2695.65%3.18M
27.70%129.14K
29.71%128.31K
23.78%116.70K
--113.78K
--101.13K
2173.00%98.92K
--94.28K
--4.35K
Net income attributable to common shareholders
46.22%-3.60M
14.52%-3.85M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.50M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
21.90%-4.99M
8.59%-5.65M
17.98%-5.00M
8.33%-6.47M
-19.92%-6.39M
31.24%-6.18M
-155.18%-6.10M
-196.99%-7.06M
-92.22%-5.33M
-81.30%-8.99M
-19.55%-2.39M
-46.16%-2.38M
-139.09%-2.77M
-116.41%-4.96M
-10.12%-2.00M
16.40%-1.63M
26.30%-1.16M
-28.58%-2.29M
-23.62%-1.81M
76.34%-1.95M
67.73%-1.57M
45.22%-1.78M
38.09%-1.47M
-503.68%-8.23M
-285.57%-4.88M
-98.41%-3.25M
-102.58%-2.37M
---1.36M
---1.26M
-191.51%-1.64M
---1.17M
---562.30K
Basic earnings per share
-1531.18%-5.37
-2559.91%-5.89
-1880.35%-6.05
-2144.62%-7.88
-6.63%-0.33
28.83%-0.22
16.07%-0.31
21.14%-0.35
46.49%-0.31
45.38%-0.31
33.80%-0.36
17.99%-0.45
8.34%-0.58
-19.90%-0.57
31.46%-0.55
-108.60%-0.54
-125.13%-0.63
1.72%-0.47
65.83%-0.80
81.17%-0.26
85.26%-0.28
69.30%-0.48
26.38%-2.35
45.40%-1.38
42.20%-1.90
50.95%-1.57
15.87%-3.19
19.18%-2.53
81.32%-3.28
70.40%-3.21
47.52%-3.79
40.55%-3.13
-479.74%-17.55
-285.56%-10.83
-98.41%-7.23
-102.59%-5.27
---3.03
---2.81
-191.51%-3.64
---2.60
---1.25
Diluted earnings per share
-1531.18%-5.37
-2559.91%-5.89
-1880.35%-6.05
-2144.62%-7.88
-6.63%-0.33
28.83%-0.22
16.07%-0.31
21.14%-0.35
46.49%-0.31
45.38%-0.31
33.80%-0.36
17.99%-0.45
8.34%-0.58
-19.90%-0.57
31.46%-0.55
-108.60%-0.54
-125.13%-0.63
1.72%-0.47
65.83%-0.80
81.17%-0.26
85.26%-0.28
69.30%-0.48
26.38%-2.35
45.40%-1.38
42.20%-1.90
50.95%-1.57
15.87%-3.19
19.18%-2.53
81.32%-3.28
70.40%-3.21
47.52%-3.79
40.55%-3.13
-479.74%-17.55
-285.56%-10.83
-98.41%-7.23
-102.59%-5.27
---3.03
---2.81
-191.51%-3.64
---2.60
---1.25
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read enVVeno Medical Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing NVNO stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was enVVeno Medical Corp's net income for the year?

enVVeno Medical Corp posted -19.47M in net income for fiscal year 2025.

How much net income did enVVeno Medical Corp post in the last quarter?

enVVeno Medical Corp reported -3.60M in net income for the latest quarter。

What was enVVeno Medical Corp's annual operating profit?

enVVeno Medical Corp's operating income was -20.90M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.